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Neoplastic brain lesionsAbstract MR spectroscopy and apparent diffusion coefﬁcient (ADC) calculation have been used
frequently for tumour grading and differentiation during the last decade. The aim of this study is to
evaluate whether the combination of these two techniques can improve the diagnostic effectiveness
in patients with brain tumour.
Patients and methods: Thirty-six patients with histologically proven brain tumours (7 low, 13 high
grade astrocytomas, 11 metastases, and 5 meningiomas) were evaluated with cMRI, MRS and DWI
before surgery.
Results: MR spectroscopy could differentiate benign from malignant tumours but was not useful
in tumour grading. In the differentiation of malignant from benign tumours, N-acetylaspartate
(NAA), Choline (Cho), Creatine, lactate/lipid, and alanin ratios were signiﬁcant. Increase in lipid
and alanin could distinguish metastases and meningiomas from other tumours. Increase in the
lactate level correlated with the degree of malignancy. ADCs were effective for grading malignant
tumours but not for distinguishing tumour types with the same grade. High grade malignant tumours had
lower ADC values (0.428+ 0.006 · 10–3 mm2/s) than did low grade malignant (1.6+ 0.325 · 10–3 mm2/s),
and benign (1.200+ 0.707 · 10–3 mm2/s) tumours.
Conclusion: The combination ofMRSwith cMRI and calculated ADC values addedmore andmore infor-
mation toMR imaging in the differentiation and grading of brain tumours and were more useful when done
together than each alone.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Accurate diagnosis is essential for optimum clinical manage-
ment in patients with intracranial tumours (1). When accessi-
ble, most tumours are surgically resected, however there is a
balance between removing as much tumour tissue as possible
while maintaining vital brain functions, and radiotherapy is
486 Abdel-Monem N. Darweesh et al.often used to treat any remaining cancerous tissue (2).
Currently there is widespread use of MRI to determine tumour
extent for surgical and radiotherapy planning, as well as for
post-therapy monitoring of tumour recurrence or progression
to higher grade. MRI provides an initial diagnosis of an intra-
cranial mass lesion with a success rate of 30–90% depending
on tumour types (3,4). However biopsy is still generally consid-
ered the gold standard for determining the cancer type and
degree of malignancy (5).
The advantage of MRS has added to the diagnostic
capabilities enabling tissue characterization based on their
molecular composition. It provides information about cell
proliferation, degradation, neuronal vitality and energy metab-
olism. Based on these characteristics, MRS attempts to differ-
entiate between benign and malignant brain lesions (6,7).
Diffusion-weighted imaging (DWI) is based on the random
or Brownian motion of water molecules in relation to their
thermal energy. DWI has been used to assess brain tumours
and while it has had limited success as a deﬁnitive prognostic
tool, its proponents suggest that in certain settings it can
increase both the sensitivity and speciﬁcity of MR imaging (8).
Calculated apparent diffusion coefﬁcient (ADC) values
from tumoural core and speciﬁc relative metabolite ratios ac-
quired by MR spectroscopy added more and more information
to MR imaging in the differentiation and grading of brain
tumours (9).
1.1. Aim of the work
The aim of this study is to evaluate the role of magnetic
resonance spectroscopy and diffusion weighted imaging in
the differentiation and grading of brain tumours.
1.2. Patients and methods
This study included 36 patients (17 males and 19 females) and
their ages ranged from 17 years to 76 years. All the Patients
were referred to diagnostic radiology and medical imaging
department at the Tanta University Hospital with symptoms
of neoplastic brain lesions.
Informed consent was obtained from all patients after full
explanation of the beneﬁts and risks of the procedure. All
patients were subjected to full clinical evaluation and speciﬁc
laboratory investigations. All patients underwent MRI study
of the brain.
2. MRI examination of brain
All the cases were evaluated by conventional MRI technique
using a 1.5 Tesla superconducting MR scanner. All cases were
examined in a supine position with a standard circularly
polarized head coil.
Axial T1 WI [400/14 ms (TR/TE)] spin echo, T2 WI (4000/
127 ms) turbo spin-echo and fast ﬂuid attenuation inversion
recovery (FLAIR) [9000/127/2800 ms (TR/TE/TI)] were
obtained by using 5 mm section thickness.
After intravenous administration of gadolinium-DTPA
(0.2 mg/kg) contrast enhanced T1 Weighted spin echo se-
quence was obtained in axial, coronal and sagittal planes. In
all cases, normal, tumoural and peritumoural regions were de-
ﬁned on the bases of the following imaging features: Normal
tissue, an area containing no enhancement and normal signalintensity on T2 WIs and (FLAIR); tumoural area, a region
containing a well-deﬁned solid portion, contrast enhancement
and abnormal signal intensity on T2 WIs and (FLAIR); peri-
tumoural area, a region containing no enhancement and shows
high signal intensity on T2 WIs and (FLAIR).
We evaluated the cMRI commenting on the lesion signal
characteristics, and the presence of haemorrhage, necrosis,
peritumoural oedema, mass effect and contrast enhancement.
3. MR spectroscopy of brain lesions
Some cases were evaluated by single voxel spectroscopic tech-
nique (SVS), and the other cases were evaluated by multivoxel
spectroscopic technique (MRS).
3.1. Voxel positioning
In SVS, the voxel was positioned in solid suspicious lesions
seen in post contrast T1 WIs avoiding areas that show haem-
orrhage or necrosis, also avoiding contamination from nearby
bone or CSF spaces, the voxel size of 2 · 2 · 2 cm3 was em-
ployed , another similar voxel was positioned on the contra lat-
eral normal brain white matter to obtain a reference spectrum.
In MVS we added multiple voxels of the same foremen-
tioned size in the peritumoural oedema.
3.2. Pulse sequence
We used point resolved spectroscopy (PRESS) with parame-
ters TR/TE 1000/144 and 1500/35.
Both intermediate and short TE (144 & 35 ms) respectively
were used, intermediate TE was used to clearly visualize peak
intensity of CHO, Cr, and NAA, to obtain CHO/Cr ratio, and
to determine the presence of Lac, while short TE was mainly
used to illustrate Lip peak.
3.3. Spectroscopic data analysis
The time domain signal intensity was processed to remove the
residual water signal. Post processing of the spectroscopic data
consisted of frequency shift, phase and linear baseline correc-
tions after Fourier transformation.
Frequency domain curve was ﬁtted to Gaussian line shape
by using the software provided by the manufacturer to deﬁne
NAA at 2.02 ppm, CHO at 3.22 ppm, Cr at 3.01 ppm, Lip at
0.9 and 1.33 ppm, and Lac at 1.33 ppm metabolic values were
calculated anatomically from the area under each metabolic
peak using the standard commercial software programme pro-
vided by the manufacturer and expressed as percentage of the
corresponding metabolites of the reference spectrum and from
these metabolic values the CHO/Cr ratio was obtained. Lip
and Lac which are not detectable in the normal brain were nor-
malized using Cr of the contra lateral reference spectrum as an
internal standard and those values were referred to as Lip level
and Lac level.
4. Diffusion imaging with apparent diffusion coefﬁcient
calculation of brain lesions
DW images were obtained by using an axial echo – planar SE
sequence (6000/92 ms) [TR/TE], one average, 5-mm section
Evaluation of neoplastic brain lesions 487thickness. DW images and ADC maps were acquired by using
b values of 0, 500 and 1000 s/mm2 applied in the X, Y and Z
directions. Post processing of ADC maps was performed by
using standard software on a different workstation. Tumoural
core and peritumoural high signal intensity areas were sampled
manually, while preferably avoiding cystic and necrotic areas.
Standard mean ADC values were calculated automatically and
expressed in 103 mm2/s.
5. The histopathological ﬁndings were taken from patients who
underwent surgery or biopsy and follow up was done in non-
operated patients
5.1. Statistics
Statistical presentation and analysis of the present study were
conducted, using the mean value, standard deviation, and chi-
square test by SPSS V.16.
5.1.1. Mean value (X)
The sum of all observations divided by the number of
observations:
ðXÞ ¼
P
x
n
where
P
= sum and n= number of observations.
5.1.2. Standard deviation [SD]
It measures the degree of scatter of individual varieties around
their mean:Table 1 The ﬁnal histopathological results of 36 patients
presented by intracranial mass lesions.
Tumour group No. of cases (36)
Malignant n= 31(88.9%):
*A (high grade):
Anaplastic Astrocytoma 5(13.88%)
GBM 8(22.25%)
Metastases 11(30.55%)
*B (low grade):
Low grade astrocytoma 7(19.44%)
Benign n= 5(11.1%)
Meningioma 5(13.88%)
Total 36(100%)
Table 2 cMRI ﬁndings together with their ﬁnal suggested diagnosi
No of Cases Heterogencity Haemorrhage Necrosis Peritu
oedem
7 Homogenous Negative Negative 7 Nega
Positive 1 Minim
5 Homogenous 1 Negative Negative 2 Mode
Heterogenous 3 Positive 2
8 Heterogeneous Positive 2 Positive 7 Mark
Negative 6 Negative 1 Mode
11 Heterogeneous Positive 5 Negative 7 Mode
Negative 5 Positive 3 Mark
5 Homogenous 4 Negative Negative Mild
Heterogeneous 1 NegaSD ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Rjx xj2
n 1
s5.1.3. Chi-square
The hypothesis that the row and column variables are indepen-
dent, without indicating strength or direction of the relation-
ship. Pearson chi-square and likelihood-ratio chi-square.
Fisher’s exact test and Yates’ corrected chi-square are com-
puted for 2 · 2 tables.
6. Result
High quality MR examinations with appropriate histological
and follow up diagnosis were available for evaluation.
This study included 36 patients 17 males (47.2%) and 19 fe-
males (52.8%) and their ages ranged from 17 to 76 years. The
study included 2 patients below 20 years (5.56%), 22 patients
between 20–50 years (61.11%) and 12 patients above 50 years
(33.33%).
31 (88.9%) of the 36 patients had malignant tumours and 5
(11.1%) had benign tumours. On the basis of histological diag-
nosis, the malignant tumours were subdivided into 24 high
grade and 7 low grade malignant tumours. The benign tumour
consisted of 5 meningiomas (13.88%) Table 1.
The ﬁnal histopathological and follow up results of 36 pa-
tients were 7 cases of low grade glioma (19.44%), 5 cases of
anaplastic astrocytoma (13.88%), 8 cases of glioblastoma mul-
tiformis (22.25%), 11 cases of metastases (30.55%), and 5
cases of meningioma (13.88%) .
6.1. cMRI evaluation
The ﬁnal suggested cMRI diagnosis regarding the 36 patients
was, 8 cases of low grade astrocytoma, 4 cases of anaplastic
astrocytoma, 11 cases of metastases, 5 cases of meningioma,
8 cases of GBM (Table 2).
Table 3, shows a highly signiﬁcant association between
both cMRI and histo-pathological results of the studied cases
as regards meningioma and GBM and less signiﬁcant associa-
tion as regards low grade glioma, anaplastic astrocytoma and
metastases by using either chi-square test or ﬁsher exact test.
The accuracy rate was found to be 93.66%.
When comparing the cMRI results with the histopatholo-
gical results regarding the grading of glioma, cMRI diagnoseds.
mour
a
Degree of
mass eﬀect
Contrast
enhancement
Diagnosis
tive 4 Negative 6 Negative 5 Low grade glioma
al 4 Minimal 2 Faint 3
rate Moderate Intense 4 Anaplastic astrocytomas
1 Low grade glioma
ed 5 Marked 5 Intense 7 GBM 1 Metastasis
rate 3 Moderate 3
rate 5 Moderate 5 Intense 10 Metastases 1 GBM
ed 5 Marked 5
2 Mild 2 Strong Meningioma
tive 3 Negative 3
Table 3 The relation between cMRI results versus results of
the pathology among the studied cases.
Pathology cMRI X2 P
Glioma grade I–II 7(19.4%) 7(19.4%) 1.253 0.863
Glioma grade III 5(13.9%) 4(11.1%) 0.852 0.657
Glioblastoma 8(22.2%) 7(19.4%) 1.00 1.00
Metastases 11(30.6%) 10(27.7%) 0.741 0.635
Meningioma 5(13.9%) 5(13.9%) 1.00 1.00
Total 36 33 – –
Table 4 Intra lesional CHO/Cr ratio among the studied cases.
Type of tumour Range Mean ± SD No. of cases
Low grade astrocytoma 1.5–2.2 1.85 ± 0.494 7
Anaplastic astrocytoma 1.7–3.4 2.84 ± 0.657 5
GBM 2.9–9.3 5.362 ± 2.39 8
Metastases 2–5.4 3.52 ± 0.783 11
Meningioma 1.9–5 3.341 ± 0.427 5
Total – – 36
Table 5 Perilesional CHO/Cr ratios among the studied cases.
Type of Tumour Range Mean + SD No. of cases
Low grade astrocytoma 1.4–1.8 1.5 ± 0.31 7
Anaplastic astrocytoma 1.5–2.1 1.7 ± 0.52 5
GBM 1.7–5.3 3.2 ± 1.84 8
Metastases 0.9–1.2 0.95 ± 0.11 11
Meningioma 0.8–1.2 0.96 ± 0.14 5
Total – – 36
Table 7 The relation between MRS results versus results of
the cMRI among the studied cases.
cMRI MRI/MRS X2 p
Glioma grade I–II 7(19.4%) 7(19.4%) 1.253 0.863
Glioma grade III 4(11.1%) 5(13.9%) 0.852 0.657
Glioblastoma multiform 7(19.4%) 8(22.2%) 1.00 1.00
Metastases 10(27.8%) 11(30.6%) 0.741 0.635
Meningioma 5(13.9%) 5(13.9%) 1.00 1.00
Total 33 36 – –
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astrocytoma was falsely diagnosed as low grade astrocytomas),
and one case of metastases was falsely diagnosed by cMRI as
GBM and one case of GBM was falsely diagnosed as metasta-
ses. The accuracy rate was found to be 93.66%.
6.2. MRS evaluation
Calculated CHO/Cr ratios from intralesional parts showed a
signiﬁcant increase from low grade astrocytoma to high grade
astrocytoma with no signiﬁcant difference between high grade
astrocytoma (anaplastic astroctoma and GBM) and metasta-
ses CHO/Cr ratios calculated from intralesional part were
the lowest in low grade astrocytoma (1.85 ± 0.494) and the
highest in GBM (5.362 ± 2.39) (Table 4).Table 6 Shows presence of lac/lip mixture on long and short
TE.
Type of tumour Lipid/lactate No. of cases
Low grade astrocytoma 2 7
Anaplastic astrocytoma 4 5
GBM 8 8
Metastases 11 11
Meningioma 1 5Calculated CHO/Cr ratios from perilesional voxels showed
an increase in CHO/Cr ratios (more than 1.2) in the primary
tumour (Indicate perilesional inﬁltration) and a decrease in
the CHO/Cr ratio (less than 1.2) in metastases (No perilesional
inﬁltration). The perilesional CHO/Cr was used as an indicator
for differentiation between primary high grade malignant
tumour and metastases (Table 5).
Both intermediate and short TE (144 and 35 ms) respec-
tively were used to evaluate the presence of lac and lip. The
lac peak was well demonstrated on long TE while the lip peak
was much more evident on short TE. Low grade gliomas
showed low lactate and lipid. With increasing malignancy,
tumours showed increasing lac and lip peaks with a signiﬁcant
difference for lip between low and high grade astrocytoma and
metastases. The present study showed 7 cases of low grade
astrocytoma, two cases showed low lipid/lactate peaks while
in rest of the cases lipid/lactate peaks were absent. With
increasing malignancy, tumours showed increasing lipid/lactate.
All the cases of GBM and metastases show high lipid/lactate
peaks (Table 6).
Comparing the cMRI and MRS data with histopatholo-
gical results, MRS correctly diagnosed 36 cases out of 36 cases
while cMRI failed to diagnose three cases out of 36 cases
(Table 7).
Table 8, shows the comparison between cMRI results and
MRI/MRS results among the studied cases. One case of ana-
plastic astrocytoma was falsely diagnosed by cMRI as low
grade astrocytoma, but MRI/MRs correctly diagnosed it by
the pattern of increase in CHO/Cr ratios from intralesional
and perilesional voxeles, and the presence of high lipid/lactate
peaks.
Another case of metastases was falsely diagnosed as GBM
by cMRI but MRI/MRS gave the correct diagnosis by calcu-
lated CHO/Cr ratio from perilesional voxels, in case of metas-
tases perilesional voxels show normal MRS curve which
indicates no perilesional inﬁltration, but in case of GBM the
perilesional voxels show an increase in CHO/Cr whichTable 8 Comparison between cMRI, MRS and histopathol-
ogical results regarding the tumour type.
c.MRI MRI/MRS Histopathology results
Low grade astrocytoma 7 7 7
Anaplastic astrocytoma 4 5 5
GBM 7 8 8
Metastases 10 11 11
Meningioma 5 5 5
Total 33 36 36
Table 9 The ﬁnal ADC value regarding the type of tumour.
Type of tumour Range Mean ± SD No. of cases by ADC
Low grade astrocytoma 1.1–1.9 · 103 mm2s 1.6 ± 0.325 7
Anaplastic astrocytoma 0.6–1 · 103 mm2s 0.428 ± 0.006 5
GBM 0.2–0.8 · 103 mm2s 0.525 ± 0.047 7
Metastases 0.1–0.9 · 103 mm2s 0.486 ± 0.230 10
Meningioma 0.7–1.7 · 103 mm2s 1.200 ± 0.707 5
Total – – 34
Table 10 The relation between ADC value results versus results of pathology among the studied cases.
Type of tumour No. of cases by ADC No. of cases by histopathology X2 P value
Low grade astrocytoma 7(19.4%) 7(19.4%) 1.00 1.00
Anaplastic astrocytoma 5(13.9%) 5(13.9%) 1.00 1.00
GBM 7(19.4%) 8(22.2%) 1.00 1.00
Metastases 10(27.8%) 11(30.6%) 0.741 0.635
Meningioma 5(13.9%) 5(13.9%) 1.00 1.00
Total 34 36 – –
(a) Axial T1-weighted. (b) Axial T1-weighted with contrast.
(c) Axial T2-weighted. (d) DWI. (e) ADC.
Intralesional Voxel. 
(f) Long TE MRS. (g) Short TE MRS.
(h) Perilesional MRS.
Figure 1 Female patient aged 23 years, complaining of headache of 5 months duration. MRI: Intra-axial well deﬁned space occupying
lesion is seen involving the left fronto-temporal region displaying low signal in T1 WI, high signal in T2 WI and FLAIR sequence, no
enhancement after IV contrast, no surrounding oedema. Picture is suggestive of low grade astrocytoma. DWI: The lesion shows free
diffusion. ADC: The mean ADC value is 1.9 · 103 mm2/s (denoting low grade malignant tumour). MRS: Intralesional voxels show
increase in Choline and decrease in Creatine with signiﬁcant reduction of N-acetyl aspartate. Choline/Creatine about 2. Perilesional voxels
show mild increase in CHO with mild decrease in NAA, CHO/Cr about 1.5. The above MRS ﬁndings are common for primary low grade
malignant tumours. Histopathological examination revealed diffuse astrocytoma grade II.
Evaluation of neoplastic brain lesions 489indicates perilesional inﬁltration. Finally one case of GBM was
falsely diagnosed by cMRI as metastases but MRI/MRSreached the correct diagnosis. The presence of perilesional
inﬁltration excludes metastases.
(a) Axial T1-weighted. (b) FLAIR.
(c) DWI. (d) ADC.
(e) Intralesional long TE MRS (f) Intralesional short TE MRS
(g) Preilesional MRS.
Figure 2 Male patient aged 57 years old, complaining of blurring of vision one month ago. MRI: Intraaxial well deﬁned space occupying
lesion is seen in the right temporoparietooccipital region, displaying low signal intensity in T1 WI, high signal in T2 WI and FLAIR
sequence. The lesion show heterogeneous enhancement after IV contrast. The lesion is surrounding by moderate vasogenic oedema and
exerting mass effect in the form of effacement of ipsilateral cortical sulci and attenuation of occipital horn of the right lateral ventricle with
contralateral midline shif. Picture suggested GBM. DWI: Multiple small areas of restrictive diffusion were found inside the lesion. The
calculated mean ADC value 0.3 · 103 mm2/s (indicate high grade malignant lesion). MRS: Intralesional voxels show marked increase in
Choline and lipid/lactate with marked reduction of NAA and Cr, CHO/Cr 5.4 (indicate high grade malignant lesion). Perilesional voxels
show marked increase in CHO with marked reduction of NAA, CHO/Cr about 3.7 (indicate perilesional inﬁltration). The above MRS
ﬁndings are common in primary high grade malignant lesion. Histopathology reveled GBM grade IV.
490 Abdel-Monem N. Darweesh et al.6.3. Diffusion image evaluation
Calculated ADC values were not useful in the differentiation
of tumours as benign versus malignant, but they were signiﬁ-
cantly effective in grading of malignant tumours. High grade
malignant tumours had signiﬁcantly lower ADC values than
those of low grade malignant and benign tumours. No signif-
icant difference was recorded between ADC values of low-
grade malignant tumours and those of benign tumours.
As shown in Table 9, although calculated ADC values were
useful in grading malignant tumours, they could not be used to
distinguish among different tumour types in the same grade.
ADC values calculated from tumoural areas were the lowest
in anaplastic astrocytoma (0.428 ± 0.006 · 103 mm2/s) and
the highest in low grade astrocytoma (1.6 ± 0.325 ·
103mm2/s). There was no difference between ADCs to distin-
guish the metastases from high grade astrocytomas, but ADC
values were useful to distinguish high grade malignant tumours
[anaplastic astrocytoma (0.4280.006 · 103 mm2/s) and GBM
(0.525 ± .006 · 103 mm2/s)]. From low grade astrocytomas
(1.6 ± 0.325 · 103 mm2/s) Meningioma had a wide range of
ADC values (0.7–1.7 · 103 mm2/s) depending on its type
(Table 9).
Table 10, shows the relation between ADC value results
versus results of pathology and follow up among the studied
cases. ADC value is only helpful in differentiating low gradefrom high grade astrocytoma, but cannot differentiate between
high grade versus metastases tumours with accuracy
rate = 94.4% (see Figs. 1–4).
7. Discussion
Conventional magnetic resonance imaging (cMRI) is the cor-
ner stone in the initial evaluation of brain tumours (10).
However, in some instances, cMRI is not effective for the
differentiation of the tumour type or detection of the tumour
grade (9).
MRS limits the use of established invasive diagnostic ap-
proaches such as brain biopsy, which is the gold standard
for evaluating brain tumour, as brain biopsy is a heavily inva-
sive technique (11).
SVS can be performed with either long TE or short TE. The
spectra of long TE can easily detect and quantify peaks of
NAA, CHO and Cr (12).
According to Fan et al. (13) short TE on the other hand
was used to clearly visualize lip peak and to conﬁrm the pres-
ence of Lac peak.
Cases of various types of brain tumour were included in this
study and all of them showed variable degrees of increased
CHO peak and CHO/Cr ratios using long TE (144 ms). A
decrease in NAA peak and Cr peak was also detected with a
signiﬁcant increase from low grade and high grade tumour,
(a) Axial T1-weighted. (b) Axial T1-weighted with contrast.
(c) Axial T2-weighted. (d) DWI.
(e) Long TE MRS. (f) Short TE MRS.
(g) MRS of surrounding oedema.
(g) MRS of surrounding oedema.
Figure 3 Female patient aged 49 years old, known case of cancer breast. MRI: Right parietal space occupying lesion is seen close to the
midline. It display heterogeneous signal in T1 WI and T2 WI. After IV contrast, it show heterogeneous enhancement. The lesion is
surrounding by marked oedema exerting mass effect in the form of mild midline shift to the contralateral side and effacement of the
ipsilateral cortical sulci. Picture suggested of metastases. DWI: The lesion show restricted diffusion. The calculated mean ADC value
0.4 · 103 mm2/s indicated high grade malignant lesion. MRS: There is marked decrease of NAA and Cr with marked elevation of CHO.
There is high lipid/lactate peak at 1.33 ppm. CHO/Cr = 5.4 (high grade malignant lesion). Perilesional voxel show depressed CHO level
with normal CHO/Cr (Denoting no perilesional inﬁltration). The above MRS ﬁndings are common in metastases.
Evaluation of neoplastic brain lesions 491while in the short (TE 35 ms), the lip level showed a signiﬁcant
difference between low grade and high grade tumours.
This study, included various types of brain tumours (20
cases of gliomas, 11 cases of metastases and 5 cases of menin-
igioma). All these cases showed increased CHO peak and
CHO/Cr ratio with a signiﬁcant increase from low grade to
high grade tumours. Other features of malignant neoplastic tis-
sue were also encountered, these included decrease in NAA
and Cr and presence of lip and lac.
Gliomas have been graded on the basis of CHO/Cr and the
presence of lipid/lactate peak. CHO/Cr ratios have shown con-
sistency in predicting the tumour grade. The comparison of
CHO/Cr ratios in high grade astrocytoma with that of low
grade gliomas provided a signiﬁcant difference between the
two groups. Lipid/lactate resonance has been observed in high
grade gliomas especially in areas of MR imaging-detectable
necrosis.
Chen et al. (14) added that the increase in CHO/Cr ratios in
high grade glioma that were higher than those found in low
grade glioma was signiﬁcantly correlated with the expression
of proliferating cell nuclear antigen that was determined im-
muno-histologically, which reﬂect the proliferative potential
of gliomas and hence their prognosis.
Among the four mentioned changes that occur in tumour
spectrum, the abnormality speciﬁc to tumours was the elevated
CHO. According to Moller-hartman et al. (10), this increase in
CHO reﬂects the elevated cell membrane turnover, andconsequently it can be used as marker of proliferating tissue
and hence it can be used to deﬁne malignant neoplastic tissue.
One case of metastases was included in the study, cMRI fal-
sely diagnosed it as GBM because both tumours gave similar
imaging features regarding signal intensity, mass effect, and
contrast enhancement. On evaluation of MRS ﬁndings of this
case of metastases there was a very characterizing feature dif-
ferentiating GBM from metastases as the latter showed a high
Choline level, large and prominent lipid peak, very little NAA
peak and absence of elevated CHO peak and CHO/Cr ratio in
the surrounding peritumoural oedema.
Accurate histopathological diagnosis of brain tumour is
essential for their management. In our study cMRI alone gave
correct grading in 18 cases out of 20 cases of glioma with a two
grade difference. One case in which cMRI diagnosed it as low
grade astrocytoma turned out to be anaplastic astrocytoma.
Anaplastic astrocytoma was characterized by high CHO/Cr
and the presence of prominent lip/lac peak.
In this study one case of GBM was falsely diagnosed as gli-
omatosis cerebri versus metastases. But MRS gave a correct
diagnosis. Interpreting MRS data with cMRI helps to reach
the correct diagnosis.
According to Galanaud et al. (15) spectra of gliomatosis
cerebri were characterized by markedly elevated Cr as well as
reduced NAA and moderately elevated CHO level.
MRS can help in detecting some of the brain tumours such
as meningioma. In this study, there was total agreement
492 Abdel-Monem N. Darweesh et al.between cMRI, MRS, and histopathologicaly results in all the
5 cases of meningioma included in the study.
We detected alanin in three of ﬁve meningiomas and its le-
vel was signiﬁcantly high to differentiate meningiomas from
other benign and malignant tumours. Another speciﬁc MR
spectroscopic ﬁnding for meningioma reported the absence
or very small peak of neuronal markers NAA and Cr, and
markedly elevated CHO. These results were similar to many
previous studies like (16–18).
Sometimes it is difﬁcult to differentiate primary from sec-
ondary brain tumours using cMRI alone, as both tumours
could give similar imaging features, in such situations MRS
can help in distinguishing both tumours. According to Ishi-
maru et al. (19) metastatic brain lesions in contrast to primary
ones show very little NAA peak or even no detectable peak at
all, because metastases do not contain neuro-glial tissue which
is responsible for the NAA peak and absence of elevated CHO
peak and CHO/Cr ratio in the surrounding peritumoural
oedema.
In this study 11 cases of metastases were included, cMRI
gave correct diagnosis in 10 cases, while MRS was able to
establish a correct diagnosis in all the 11 cases by detecting
the increased CHO peak. NAA and Cr levels were signiﬁcantly
lower in metastases than in gliomas, also metastases showed a
very large Lip peak even in the absence of necrosis and absence
of elevated CHO peak and CHO/Cr ratio in the surrounding
peritumoural oedema.- 
(a) Axial T1-weighted. (b) Axial T1-weighted with contrast.
(c) Axial T2-weighted. (d) DWI.
Figure 4 Female patient aged 50 years old complaining of blurring o
occupying lesion is seen displaying isointense signal in T1 WI and hyper
The lesion is surrounded by mild vasogenic oedema. Picture suggested
mean ADC value 1.6 · 103 mm2/s denoting benign lesion. MRS: Int
NAA and Cr, which is common for meningioma. Perilesional voxel
examination reveald meningioma.Dowling et al. (20) gave a possible explanation for the ele-
vated lipids in metastasis lesions as the cancer cells of different
origin, which have the potential to metastases, contain mobile
spectroscopically detectable lipids in their cell membrane,
while cell cultures of tumours which do not lead to metastases
do not exhibit these mobile lipids.
The second major ﬁnding of this study was diffusion-
weighted imaging it can increase both the sensitivity and spec-
iﬁcity of MR imaging in the evaluation of brain tumours by
providing information about tumour cellularity, which may
in turn improve prediction of tumour grade (8).
Calculated ADC values were signiﬁcant and useful in the
grading of malignant tumours. We could not ﬁnd any signiﬁ-
cance for the differentiation of the tumours. ADC values ob-
tained from tumour were signiﬁcant in grading tumours but
not in differentiating different tumour types in the same grade
(21).
In our study, ADC values calculated from primary tumour-
al area had the lowest values in high-grade malignant tumours.
We could not ﬁnd any difference among the ADCs of the tu-
mour types in the same grade. This was similar to many studies
like.
ADC could not be used in individual cases differentiate tu-
mour types. Calculated ADC from tumoural area were signif-
icantly higher in low-grade malignant tumours than in high-
grade ones (22), the lower ADCs suggested high-grade astrocy-
tomas, whereas higher ADCs suggested low-grade ones.Intralesional Voxel
(e) Long TE MRS. (f) Short TE MRS.
(g) Perilesional  MRS. 
f vision 3 months duration. MRI: Left occipital extra-axial space
intense signal in T2 WI with strong enhancement after IV contrast.
meningioma. DWI: There is restrictive diffusion. The calculated
ralesional voxels show marked elevation of Choline with very low
show normal spectroscopy curve. Pathology: Histopathological
Evaluation of neoplastic brain lesions 493The benign tumours had ADC values higher than those of
high-grade malignant tumours and but not higher than those
of low grade malignant tumours. Meningiomas, had a wide
range of ADCs. Meningiomas with low ADC values tended
to be malignant or highly atypical whereas meningiomas with
the highest ADC values had increased water content due to
either a speciﬁc histologic subtype of meningioma or the pres-
ence of associated pathologic abnormality (23,24).
Last but not least, diagnosis of primary and secondary
brain tumours and differentiating them from other focal in-
tra-cranial lesions based on imaging procedures alone is still
a challenging problem, in this study it was found that combi-
nation of proton MRS and ADC calculation can provide addi-
tive valuable information helping in tissue characterization of
intra-cranial tumours leading to improved diagnosis and hence
management and prognosis.
8. Conclusion
As a conclusion from our results the accuracy of cMRI alone
in the diagnosis of brain tumours was 91.6%, with aiding ADC
value, the accuracy rate was 94.4% and by combination of MR
spectroscopy with both cMRI and calculated ADC values the
accuracy rate markedly elevated.
So the combination of MRS with cMRI and calculated
ADC values added more and more information to MR imag-
ing in the differentiation and grading of brain tumours and
were more useful when done together than each alone.Conﬂict of interest
We have no conﬂict of interest to declare.
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